Johan Forslund, MD
Adult Reconstructive Orthopaedic Surgery · Fullerton, CANPI 1982138665
Payments from drug & device makers
Across 79 payments — averaging $128.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6K
- Stryker$2K
- Zimmer Biomet$1K
- Globus Medical$248
- Medtronic$124
- Medical Device Business Services, Inc.$54
- plus $114 from 6 others
What the payments were for
- Travel & lodging$2,68927%
- Food & beverage$3,76537%
- Education$3,67136%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 14 | $5,972 |
| Stryker | 28 | $2,303 |
| Zimmer Biomet | 15 | $1,310 |
| Globus Medical | 13 | $248 |
| Medtronic | 1 | $124 |
| Medical Device Business Services, Inc. | 2 | $54 |
| Heron Therapeutics, Inc. | 1 | $29 |
| Innovation Technologies Inc | 1 | $22 |
| Elevate Surgical Co | 1 | $18 |
| KCI USA, Inc. | 1 | $18 |
| Convatec Inc. | 1 | $15 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REAL INTELLIGENCE$2,914
- PROFYLE$941
- Persona$623
- Smith & Nephew Insufflator 500$529
- Oxford$249
- VARIAX$175
- T2$171
- INSIGNIA$168
- Journey II$128
- Legion Revision$128
- K-15 PORK$128
- LigaSure$124
- GAMMA$106
How this compares
$10,125 in reported general payments places this provider in the 50th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $8,163 |
| Celecoxib | 80 | $2,183 |
| Oxycodone Hcl | 173 | $962 |
| Cefadroxil | 114 | $595 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $339 |
| Pregabalin | 18 | $270 |
| Ondansetron OdtOndansetron | 30 | $253 |
| Tramadol Hcl | 70 | $242 |
| Methylprednisolone | 37 | $227 |
| Dexamethasone | 102 | $182 |
| Ondansetron Hcl | 48 | $167 |
| Amoxicillin | 66 | $153 |
| Gabapentin | 15 | $75 |
| Meloxicam | 15 | $21 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Fullerton
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- James HuddlestonStanford$2.2M
- William Bugbeela Jolla$2.2M
- Alexander SahFremont$1.8M
- John DianaNapa$1.1M
- Louis KwongTorrance$958K
- Derek AmanatullahStanford$935K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.